You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
Confirmatory Study of Eteplirsen in DMD Patients (PROMOVI)
|
|---|---|
| Registered in |
ClinicalTrials.gov, September 2014
|
| Information provided by |
Sarepta Therapeutics |
| ClinicalTrials.gov ID |
X Demographics
The data shown below were collected from the profiles of 67 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 27 | 40% |
| Canada | 3 | 4% |
| United Kingdom | 2 | 3% |
| Australia | 1 | 1% |
| Spain | 1 | 1% |
| Germany | 1 | 1% |
| Côte d'Ivoire | 1 | 1% |
| Argentina | 1 | 1% |
| Unknown | 30 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 59 | 88% |
| Scientists | 4 | 6% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
| Practitioners (doctors, other healthcare professionals) | 1 | 1% |
| Unknown | 1 | 1% |
Attention Score in Context
This research output has an Altmetric Attention Score of 93. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2022.
All research outputs
#468,689
of 25,832,559 outputs
Outputs from ClinicalTrials.gov
#819
of 23,619 outputs
Outputs of similar age
#4,513
of 263,992 outputs
Outputs of similar age from ClinicalTrials.gov
#37
of 1,129 outputs
Altmetric has tracked 25,832,559 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 23,619 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 263,992 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 1,129 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.